Statins: Can we advocate them for primary prevention of heart disease?-Reference-Cited by-同舟云学术

Statins: Can we advocate them for primary prevention of heart disease?

Published:2014-07 Issue:3 Volume:70 Page:270-273
ISSN:0377-1237
Container-title:Medical Journal Armed Forces India
language:en
Short-container-title:Medical Journal Armed Forces India

Author:

Ray Sougat,Jindal A.K.,Sengupta S.,Sinha S.

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era;Lazar;Circulation,2011

2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice;Harley;Am J Geriatr Pharmacother,2007

4. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis;Law;Br Med J,2003

5. Statin therapy in the prevention of recurrent cardiovascular events – a sex-based meta-analysis;Jose;Arch Intern Med,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study;All Life;2024-03-12

2. Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function;Journal of the American College of Cardiology;2022-08

3. Toxicology and Pharmacokinetics Study of Intradiscal Injection of Simvastatin in Rabbits;Frontiers in Pharmacology;2021-04-23

4. Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis;Current Pharmaceutical Design;2019-01-22

5. Atorvastatin improves left ventricular remodeling and cardiac function in rats with congestive heart failure by inhibiting RhoA/Rho kinase‑mediated endothelial nitric oxide synthase;Experimental and Therapeutic Medicine;2018-11-16